MENU

A big week for type 1 diabetes
Published on October 23, 2015
Community Stories

Dear Friends You may have seen quite a bit of media recently about attempts to encourage the Government to fund Continuous Glucose Monitors (CGMs). There has been some widespread coverage of work being done particularly by the Danii Meads Barlow Foundation and Donna Meads-Barlow, as well as Diabetes Australia and JDRF. It is great to […]

Share
Preventing T1D using an immune system protein
Published on September 15, 2015

New research from Sweden has shown promising progress in the use of the anti-inflammatory protein interleukin-35 (IL-35) for preventing T1D. IL-35 is produced by regulatory T-cells (Tregs), which control and direct the activity of different components of the immune system. In a healthy immune system, IL-35 helps to suppress inflammation and prevent killer immune cells […]

Share
Insulin pumps reduce risk of fatal heart disease
Published on September 14, 2015

Cardiovascular disease, or heart disease, can be a complication of type 1 diabetes (T1D) due to the uncontrolled rise and fall of blood sugar levels damaging nerves and blood vessels. A new study has now shown that adults could reduce their risk of fatal heart disease by using insulin pump therapy instead of multiple daily […]

Share

Media Release 9 September 2015 Australian research boosted with $14 million diabetes grants Today the Hon. Christopher Pyne, Minister for Education and Training, announced over $14 million in grants for research into type 1 diabetes, a chronic disease affecting more than 120,000 Australians. The grants are issued by the Type 1 Diabetes Clinical Research Network […]

Share
JDRF says thanks to Professor Martin Silink AO
Published on August 28, 2015

In 1982, a group of Australian parents came together to form what became known as the Diabetes Youth Foundation. Years later, the DYF became JDRF Australia. One year after they formed, the DYF made their first ever “Getting Started” grant to the only paediatric endocrinologist in Australia at the time, Professor Martin Silink. The $7000 […]

Share
New $400m partnership for beta cell therapy development
Published on August 17, 2015

Long-time JDRF partner Sanofi and European biotech company Evotec have forged a $400m partnership to develop beta-cell therapies for people with type 1 diabetes. This new strategic collaboration between Sanofi and Evotec is aiming to develop a beta cell replacement therapy for people with T1D, by creating insulin-producing beta-cells from human stem cells. They will […]

Share
Google partnership for tiny CGMs
Published on August 13, 2015

Leading diabetes device manufacturer DexCom has signed a deal with Google Life Sciences to build miniature continuous glucose monitors (CGMs). The companies will jointly design the next-generation CGMs, which will be smaller than a 5 cent coin and will combine Google’s miniaturisation expertise with DexCom’s cutting-edge glucose sensor technology. The first stage of development under […]

Share
Insulin pill shows promise as T1D vaccine
Published on July 17, 2015

A JDRF-supported clinical trial in Germany has shown that a simple insulin pill may be able to prevent type 1 diabetes. When the pills were given to children at high-risk of developing T1D, their immune systems showed signs of becoming more tolerant to insulin. This tolerance could prevent the immune system from attacking the insulin-producing […]

Share
Feel In Charge of Your Diabetes Online!
Published on July 1, 2015

Our friends at the Black Dog Institute are running an online trial for young Australians with T1D. Associate Professor Judy Proudfoot explains the trial, and how you can get involved. My experience is in the design, development and evaluation of digital programs for improving mental health and wellbeing. As the Head of eHealth at the Black […]

Share